Medical System Network Co., Ltd. (4350.T) stock price, financials & research

Regular session · JST · Market data may be delayed.

Company profile

Headquartered in Sapporo, Japan, and established in 1999, Medical System Network Co., Ltd. functions as a comprehensive provider within the healthcare industry. Its core business involves the distribution of pharmaceutical products to a diverse range of clients, including pharmacies, hospitals, clinics, and drug wholesalers. The company's operations are divided into several key segments. The Community Pharmacy Network division primarily facilitates the procurement and sale of pharmaceuticals among pharmacies, hospitals, clinics, and wholesale distributors. This segment also delivers crucial inventory management and liquidation services, manufactures and markets its own pharmaceutical offerings, and handles price negotiations with suppliers. Furthermore, it maintains a specialized platform designed to assist with pharmacy transitions. Within the Leasing and Facility-related segment, Medical System Network provides building rental services, develops optimal locations for new pharmacies, and offers consulting expertise to medical practitioners. The Meal Catering segment is responsible for delivering food services to hospitals and various welfare facilities. Beyond these primary areas, the company also offers nursing care and specialized advisory counseling services tailored for the medical treatment sector.

Industry: Medical - Pharmaceuticals
Sector: Healthcare
Headquarters: JP
CEO: Inao Tajiri
Listed since: Sep 5, 2008
Employees: 4,014

Market position

Day range

Current ¥494

¥476¥496

52-week range

Current ¥494

¥433¥558

Open: ¥488
Previous close: ¥487
Volume: 120.1K; 1.53× average
Average volume: 78.65K; Average daily volume
Market cap: 14.44B JPY
Beta: 0.51; Market reference 1
50-day average: ¥481.3; +2.64% above average
200-day average: ¥506.1; -2.39% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM): 16.63×
P/B (TTM): 0.85×
P/S (TTM): 0.11×
Dividend yield: 2.43%

Profitability & efficiency

Gross margin: 40.25%
Operating margin: 2.23%
Net margin: 0.65%

Financial health

Debt / equity: 1.79×
Altman Z-score: 2.14
Piotroski F-score: 4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

132.19B JPY+8.01%

Operating income

3.31B JPY+5.07%

Net income

1.07B JPY-15.20%

Metric (JPY)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	132.19B JPY	122.39B JPY	115.36B JPY	109.55B JPY	106.69B JPY
Cost of goods sold	79.42B JPY	72.78B JPY	67.44B JPY	63.63B JPY	62.26B JPY
Gross profit	52.77B JPY	49.6B JPY	47.93B JPY	45.92B JPY	44.43B JPY
Selling, general, and administrative	49.45B JPY	46.45B JPY	37.45B JPY	36.51B JPY	34.51B JPY
Operating expenses	49.45B JPY	46.45B JPY	44.09B JPY	42.76B JPY	40.58B JPY
Interest income	9M JPY	3M JPY	1M JPY	2M JPY	1M JPY
Interest expense	343M JPY	278M JPY	288M JPY	277M JPY	183M JPY
Depreciation and amortization	3.42B JPY	3.41B JPY	3.16B JPY	2.96B JPY	2.86B JPY
Operating income	3.31B JPY	3.15B JPY	3.83B JPY	3.16B JPY	3.85B JPY
Net income	1.07B JPY	1.26B JPY	1.86B JPY	1.61B JPY	2.39B JPY